Skip to search formSkip to main contentSkip to account menu

Rifabutin:MCnc:Pt:Ser/Plas:Qn

Known as: Rifabutin:KütlKons:Zml?:Ser/Plaz:Kant, Rifabutin:Mass Concentration:Point in time:Serum/Plasma:Quantitative, rifabutina:concentración de masa:punto en el tiempo:suero/plasma:cuantitativo 
National Institutes of Health

Related topics

Related topics

4 relations
PlasRifabutinSerumUnit of Mass Concentration

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
THE SAFETY ASSESSMENT OF RIFABUTIN NANOFORMULATIONS
2014
2014
Rifabutin İlişkili Üveit ve İmmün Düzelme Üveiti Birlikteliği
2000
2000
Affektionen der vorderen Augenabschnitte bei HIV-Infektion nach Einführung der hochaktiven antiretroviralen Therapie (HAART)1 2 3
The clinical picture of HIV-associated eye disease has changed dramatically since the introduction of highly active… 
1996
1996
Rifabutin-induzierte Hypopyoniritis bei HIV-Infektion
BACKGROUND: Rifabutin is a new semisynthetic rifamycin which is approved in Germany for clinical application since 1/15/95. The… 
1996
1996
Antivirals key to MAC prevention regimen.
Prophylaxis for Mycobacterium avium complex (MAC) should be considered standard treatment for all patients with advanced HIV… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)